ArticleBlood2018

Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL.

Sean D Reiff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.